Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 15, 2007

View Archived Issues

Nastech reacquires teriparatide nasal spray for osteoporosis from Procter & Gamble

Novel MAO-B inhibitors developed at Roche

Novel antiinfective agents disclosed in recent patent literature

SantoSolve raises USD 7 million to support initiation of phase III clinical trial of 2-PX

Studies show reduced albuminuria with aliskiren in diabetes patients

Neuroprotective gene in AD identified by Siena Biotech

FDA accepts Chelsea Therapeutics' IND for droxidopa

Synvista Therapeutics initiates phase II clinical trial of alagebrium for chronic heart failure

BioMS Medical enrolls first 133 patients in MAESTRO-03 phase III trial of MBP-8298

Novel treatment option for transplant rejection imparted in recent Novartis patent

Lexicon submits NDA to FDA for LX-2931 for rheumatoid arthritis

New antiinflammatory agents disclosed in recent Kalypsys and Abbott patents

Actelion initiates CONSCIOUS-2 phase III study of endothelin receptor antagonist Pivlaz

Synta initiates SYMMETRY phase III clinical trial of elesclomol in metastatic melanoma

ImmuneRegen reports positive findings on effectiveness of Viprovex against flu virus

Rigel reports positive results from phase II clinical study of R-788

Acambis collaborates with sanofi pasteur to develop West Nile virus vaccine

TMC-125: Study results presented at the 11th European AIDS Conference

MLN-1202 lowers CRP in patients with atherosclerotic cardiovascular disease risk

Prucalopride well tolerated and improves bowel function in chronic constipation

Declines in HCV RNA seen with VCH-759 in multiple-dose study

SEACOAST study reveals efficacy of Simcor in dyslipidemia

PD-0348292 inhibits thrombosis in pigs undergoing iliac venous stent placement

Anti-HCV effect of R-1626 with peginterferon alfa-2a, R-1626 resistance studied

Enrollment begins for RH1 study in solid tumors or non-Hodgkin's lymphoma

FDA grants fast track status to Crucell's rabies monoclonal antibody cocktail

E.U. approves Pegintron/Rebetol therapy for HCV patients failing interferon therapy

FDA approves Mircera for renal anemia indication

Mitsubishi Tanabe receives Japanese approval for extended indication of Remicade

Fastic/Starsis receives approval for supplemental NDA in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...